Product Images Ziprasidone Mesylate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Ziprasidone Mesylate NDC 72205-205 by Novadoz Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
zipra-inj-10s-carton-label - zipra inj 10s carton label
Ziprasidone Mesylate for Injection is a sterile medication available in a box containing 10 single-dose vials for intramuscular use only. The NDC number is 72205-205-07, and it is produced by NOVADOZ. Users are advised to protect the contents from light. No other relevant information was provided.*
str - zipra inj structure
zipra-inj-vial-label - zipra inj vial label
This is a product description for Ziprasidone Mesylate for Injection. It contains 2 mg of Ziprasidone and 4.7 mg of Methanesulfonic acid and is administered intramuscularly. The powder must be reconstituted with 1.2 mL of sterile water for injection. The resulting solution has a concentration of 20 mg/mL. Dosage and usage information should be obtained from accompanying prescribing information. This product is distributed by Novador Pharmaceuticals and the reconstitution process should be done in light-protected areas.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.